gene-therapy-manufacturing
13 Results
Advanced Search
Showing
Products (0)
Documents (0)
Site Content (13)
-
-
Test | Gene Therapy Manufacturing | Merck
Our BioReliance® testing services provide the optimal balance between speed and customization and give you the confidence to get therapies to market quickly and safely. -
Grow | Gene Therapy Manufacturing | Merck
Lack of process templates and compressed timelines create unique challenges for growing your viral vectors. You need to make choices quickly knowing that these decisions have an impact on downstream processes. -
Learn | Gene Therapy Manufacturing | Merck
Gene therapy best practices, application and process information. -
Manufacture | Gene Therapy Manufacturing | Merck
Our BioReliance® viral and gene therapy manufacturing site at Carlsbad is a contract development and manufacturing organization (CDMO) that provides a complete range of services in the viral and gene therapy life cycle. -
Purify | Gene Therapy Manufacturing | Merck
The gene therapy industry is facing increasing pressure to decrease manufacturing costs, shorten process development timelines and increase production. -
Formulate | Gene Therapy Manufacturing | Merck
With our application know-how and regulatory expertise, we support you throughout the entire formulation process. -
Press Release: Merck Builds on Leading Viral and Gene Therapy Service Offering with Capacity Expansion
Merck today announced an expansion of its Carlsbad, California facility to meet growing demand for viral and gene therapy products. -
BioReliance® Cell and Gene Therapy Testing Services | Merck
Our BioReliance® gene therapy services provide the confidence to get products to market quickly and safely. -
Event | BioProcess International US West | Virtual Conference | Merck
We look forward to the upcoming virtual BioProcess International US West conference where you can join our sessions to learn more about Reducing steps and increase throughput for your seed train, Biopharma industry's current AI maturity level and future applications, Use of advanced analytics in IDing outlier batches and Insights on the Path from Research to Commercialization for Gene Therapy